SPDR Series Trust - State Street SPDR S&P Biotech ETF
US ˙ ARCA ˙ US78464A8707

SecurityXBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
InstitutionLegacy Bridge, LLC
Latest Disclosed Ownership11,209 shares
Latest Disclosed Value $ 1,431,726
Legacy Bridge, LLC reports 0.80% decrease in ownership of XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF

On May 14, 2026 - Legacy Bridge, LLC filed a 13F-HR form disclosing ownership of 11,209 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF (US:XBI) valued at $1,431,726 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 11,299 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF. This represents a change in shares of -0.80% during the quarter. The current value of the position is $1,455,264 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 11,209 -90 -0.80 1,432 3.92 0.5460
2026-01-23 2025-12-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 11,299 845 8.08 1,378 31.52 0.5592
2025-11-12 2025-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 10,454 -455 -4.17 1,047 15.82 0.4359
2025-08-06 2025-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 10,909 -7,645 -41.20 905 -39.89 0.4294
2025-05-08 2025-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 18,554 -600 -3.13 1,505 -12.81 0.8396
2025-01-22 2024-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 19,154 25 0.13 1,725 -8.68 0.8993
2024-11-07 2024-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 19,129 8 0.04 1,890 6.60 1.0177
2024-08-06 2024-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 19,121 18,357 2,402.75 1,773 2,361.11 1.0449
2024-04-25 2024-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 764 467 157.24 72 176.92 0.0424
2024-01-17 2023-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 27 23.81 0.0172
2023-10-11 2023-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 22 -12.50 0.0155
2023-07-11 2023-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 25 9.09 0.0165
2023-04-24 2023-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 23 -8.33 0.0158
2023-01-11 2022-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 25 0.00 0.0175
2022-11-02 2022-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 24 9.09 0.0191
2022-07-21 2022-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 22 -18.52 0.0162
2022-04-28 2022-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 27 -18.18 0.0158
2022-01-18 2021-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 33 -10.81 0.0172
2021-10-26 2021-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 37 -7.50 0.0213
2021-08-03 2021-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 40 0.00 0.0226
2021-04-29 2021-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 297 -297 -50.00 40 -52.38 0.0259
2021-02-02 2020-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 594 0 0.00 84 27.27 0.0609
2020-10-19 2020-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 594 0 0.00 66 0.00 0.0603
2020-08-04 2020-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 594 297 100.00 66 186.96 0.0726
2020-05-01 2020-03-31 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 297 0 0.00 23 -17.86 0.0290
2020-04-09 2020-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 297 0 23 29,173.7487
2020-02-04 2019-12-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 297 0 0.00 28 21.74 0.0233
2019-10-15 2019-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 297 0 0.00 23 -11.54 0.0220
2019-07-11 2019-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 297 0 0.00 26 -3.70 0.0251
2019-04-26 2019-03-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 297 0 0.00 27 28.57 0.0278
2019-01-25 2018-12-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 297 297 21 0.0260
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.